NeoGenomics Company Profile (NASDAQ:NEO)

About NeoGenomics

NeoGenomics, Inc. is an operator of a network of cancer-focused genetic testing laboratories. The Company operates in Laboratory Testing Segment. Its Laboratory Testing segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. The Company offers testing services, which includes Cytogenetics testing, which is the study of normal and abnormal chromosomes and their relationship to disease; fluorescence in-situ hybridization (FISH) testing, which is a branch of cancer genetics that focuses on detecting and locating the presence or absence of specific deoxyribonucleic acid (DNA) sequences and genes on chromosomes; flow cytometry testing, which is a way to measure the characteristics of cell populations, and immunohistochemistry (IHC), and digital imaging, which is a process of localizing proteins in cells of a tissue section and relies on the principle of antibodies binding specifically to antigens in biological tissues.

Industry, Sector and Symbol:

• Sector: Medical
• Industry: Medical Laboratories & Research
• Sub-Industry: N/A
• Exchange: NASDAQ
• Symbol: NEO
• CUSIP:

Key Metrics:

• Previous Close: $8.33
• 50 Day Moving Average: $8.10
• 200 Day Moving Average: $8.01
• 52-Week Range: $77,893,000.00 - $5.49
• Trailing P/E Ratio: N/A
• Foreward P/E Ratio: 39.67
• P/E Growth: 3.20
• Market Cap: $648.85M
• Outstanding Shares: 77,893,000
• Beta: 1.27

Profitability:

• Net Margins: -3.76%
• Return on Equity: 3.18%
• Return on Assets: 1.89%

Debt:

• Debt-to-Equity Ratio: 0.28%
• Current Ratio: 2.50%
• Quick Ratio: 2.35%

Additional Links:

• Visit NeoGenomics' Official Website
• View NEO on Google Finance
• View NEO on Yahoo Finance
• View NEO's Company Profile on Reuters
• Search for NeoGenomics Inc. on Google

Companies Related to NeoGenomics:

• Supernus Pharmaceuticals (NASDAQ:SUPN)
• Glaukos Corp. (NYSE:GKOS)
• Innoviva (NASDAQ:INVA)
• Cynosure (NASDAQ:CYNO)
• TherapeuticsMD (NYSEMKT:TXMD)
• Acorda Therapeutics (NASDAQ:ACOR)
• Air Methods Corp. (NASDAQ:AIRM)
• Inogen (NASDAQ:INGN)
• Dermira (NASDAQ:DERM)
• Achillion Pharmaceuticals (NASDAQ:ACHN)

Earnings

Earnings History for NeoGenomics (NASDAQ:NEO)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call	Details
10/27/2016
7/26/2016	Q216	$0.03	$0.04	$61.07 million	$63.10 million	View	Listen
4/27/2016	Q116	($0.07)	$0.03	$57.00 million	$59.70 million	View	Listen
3/1/2016	Q415	$0.02	($0.03)	$26.46 million	$27.30 million	View	N/A
4/28/2015	Q115	($0.02)	($0.01)	$23.36 million	$23.00 million	View	N/A
2/24/2015	Q414	$0.01	$0.02	$24.30 million	$25.00 million	View	N/A
10/30/2014	Q314	($0.01)	($0.01)	$22.43 million	$23.20 million	View	N/A
7/17/2014	Q214	$0.01	$0.01	$19.84 million	$20.70 million	View	N/A
2/19/2014	Q413	$0.02	$0.04	$17.80 million	$18.30 million	View	N/A
10/23/2013	Q313	$0.01	$0.02	$16.84 million	$16.90 million	View	N/A
7/31/2013	Q2 2013		$0.01	$16.20 million	$15.60 million	View	N/A

(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for NeoGenomics (NASDAQ:NEO)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	1	($0.01)	($0.01)	($0.01)
Q2 2016	1	$0.01	$0.01	$0.01
Q3 2016	1	$0.04	$0.04	$0.04
Q4 2016	1	$0.05	$0.05	$0.05

(Data provided by Zacks Investment Research)

Dividends

Dividend History for NeoGenomics (NASDAQ:NEO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for NeoGenomics (NASDAQ:NEO)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
9/20/2016	Maher Albitar	Insider	Sell	105,300	$8.20	$863,460.00
9/12/2016	Maher Albitar	Insider	Sell	60,075	$8.23	$494,417.25
8/19/2016	Maher Albitar	Insider	Sell	370,000	$8.23	$3,045,100.00
5/27/2016	Oort Douglas M Van	CEO	Sell	481,387	$8.73	$4,202,508.51
5/18/2016	Steven A Ross	Insider	Sell	18,000	$8.50	$153,000.00
5/9/2016	Steven A Ross	Insider	Sell	15,000	$8.22	$123,300.00
5/2/2016	Steven C Jones	VP	Sell	177,745	$8.21	$1,459,286.45
4/29/2016	Steven A Ross	Insider	Sell	112,500	$8.11	$912,375.00
3/11/2016	George Cardoza	CFO	Sell	32,000	$6.83	$218,560.00
3/9/2016	Oort Douglas M Van	CEO	Sell	450,000	$7.10	$3,195,000.00
3/3/2016	Alison L Hannah	Director	Buy	10,000	$6.90	$69,000.00
12/7/2015	Lynn A Tetrault	Director	Buy	3,500	$7.72	$27,020.00
12/3/2015	Robert J Shovlin	COO	Buy	6,550	$7.75	$50,762.50
11/27/2015	Steven C Jones	VP	Sell	385,000	$8.09	$3,114,650.00
11/2/2015	Bruce K Crowther	Director	Buy	6,400	$7.81	$49,984.00
12/19/2014	Robert H Horel	VP	Sell	32,389	$4.21	$136,357.69
12/18/2014	Robert H Horel	VP	Sell	62,893	$4.20	$264,150.60
12/4/2014	Michael T Dent	Director	Sell	11,800	$4.50	$53,100.00
11/26/2014	George Cardoza	CFO	Sell	60,000	$4.28	$256,800.00
11/21/2014	Michael T Dent	Director	Sell	33,200	$4.51	$149,732.00
5/22/2014	Robert P Gasparini	Insider	Sell	100,000	$3.49	$349,000.00
5/19/2014	Robert Gasparini	Insider	Sell	10,000	$3.65	$36,500.00
3/28/2014	Maher Albitar	Insider	Buy	14,492	$3.51	$50,866.92
3/5/2014	Michael T Dent	Director	Sell	300,000	$3.00	$900,000.00
12/11/2013	Robert P Gasparini	Insider	Sell	20,100	$3.70	$74,370.00
12/9/2013	George Cardoza	CFO	Sell	20,000	$3.66	$73,200.00
12/5/2013	Robert P Gasparini	Insider	Sell	32,996	$3.67	$121,095.32
12/3/2013	Robert P Gasparini	Insider	Sell	32,146	$3.67	$117,975.82
11/25/2013	Steven C Jones	VP	Sell	112,969	$3.58	$404,429.02
4/30/2013	Steven C Jones	Director	Sell	100,000	$3.71	$371,000.00

(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for NeoGenomics (NASDAQ:NEO)

Date	Headline
	Looking Ahead for NeoGenomics, Inc. (NASDAQ:NEO); Are These Shares Ready to Go Higher? - Frisco Fastball (NASDAQ:NEO) friscofastball.com - September 22 at 6:02 PM
	Pathogen Identification and Treatment Market by Technological Advances, 2016 – 2022 (NASDAQ:NEO) www.medgadget.com - September 22 at 11:09 AM
	Forget Novavax, Buy These 4 Biotech Stocks Instead (NASDAQ:NEO) www.nasdaq.com - September 16 at 6:05 PM
	Liquid Biopsy Market To Gain From Enhanced Demand In End-use Industries Till 2030: Grand View Research, Inc. (NASDAQ:NEO) www.abnewswire.com - September 15 at 6:25 PM
	Consensus Estimates on Earnings & Stock Price in Focus for NeoGenomics, Inc. (NASDAQ:NEO) Shares - Frisco Fastball (NASDAQ:NEO) friscofastball.com - September 14 at 10:38 AM
	NeoGenomics, Inc. (NASDAQ:NEO) Is Expected To Post EPS Of $0.01 - RealistInvestor.com (NASDAQ:NEO) www.realistinvestor.com - September 14 at 10:38 AM
	Biotech Stocks Bounce Back in Monday Trading: 3 Picks (NASDAQ:NEO) finance.yahoo.com - September 13 at 11:11 AM
	ETF’s with exposure to NeoGenomics, Inc. : September 12, 2016 (NASDAQ:NEO) www.capitalcube.com - September 12 at 6:03 PM
	Health Discovery Corporation Announces Formation of Development Committee (NASDAQ:NEO) mhealthwatch.com - September 12 at 10:59 AM
	Health Discovery Corporation Forms Development Committee (NASDAQ:NEO) www.businesswire.com - September 12 at 10:59 AM
	ETF’s with exposure to NeoGenomics, Inc. : September 2, 2016 (NASDAQ:NEO) www.capitalcube.com - September 2 at 11:12 AM
	Brazil judge suspends operating license for Belo Monte hydrodam (NASDAQ:NEO) finance.yahoo.com - September 1 at 6:19 PM
	Shares Slipping Lower Over the Past Month: Neogenomics Inc. (NASDAQ:NEO) - Post News (NASDAQ:NEO) www.kentuckypostnews.com - September 1 at 9:33 AM
	Can the Crowd & Analysts Agree on NeoGenomics, Inc. (NASDAQ:NEO)? - Post News (NASDAQ:NEO) www.kentuckypostnews.com - August 23 at 10:49 AM
	NEOGENOMICS INC Financials (NASDAQ:NEO) finance.yahoo.com - August 16 at 6:33 PM
	ETF’s with exposure to NeoGenomics, Inc. : August 15, 2016 (NASDAQ:NEO) www.capitalcube.com - August 15 at 6:41 PM
	Earnings Surprise In Focus: NeoGenomics, Inc. (NASDAQ:NEO) - Investor Newswire (NASDAQ:NEO) www.investornewswire.com - August 14 at 10:54 AM
	NeoGenomics, Inc. :NEO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 (NASDAQ:NEO) www.capitalcube.com - August 10 at 6:51 PM
	NEOGENOMICS INC Files SEC form 10-Q, Quarterly Report (NASDAQ:NEO) biz.yahoo.com - August 5 at 6:36 PM
	ETF’s with exposure to NeoGenomics, Inc. : August 4, 2016 (NASDAQ:NEO) www.capitalcube.com - August 4 at 6:46 PM
	NeoGenomics, Inc. breached its 50 day moving average in a Bearish Manner : NEO-US : August 2, 2016 (NASDAQ:NEO) www.capitalcube.com - August 2 at 11:12 AM
	Form 4 NEOGENOMICS INC For: Jul 28 Filed by: HIPP RAYMOND R - StreetInsider.com (NASDAQ:NEO) www.streetinsider.com - July 30 at 5:48 PM
	Pathogen Identification and Treatment Market : Recent Industry Trends and Projected Industry Size by 2016 – 2022 (NASDAQ:NEO) www.medgadget.com - July 29 at 6:34 PM
	ICON : How These Healthcare Stocks are Performing? -- AMAG Pharma, IDEXX Laboratories, Neogenomics, and ICON (NASDAQ:NEO) www.4-traders.com - July 29 at 9:26 AM
	How These Healthcare Stocks are Performing? -- AMAG Pharma, IDEXX Laboratories, Neogenomics, and ICON (NASDAQ:NEO) www.prnewswire.com - July 29 at 9:26 AM
	NeoGenomics Shares Nearing Full Valuation In BTIG's View (NASDAQ:NEO) www.benzinga.com - July 28 at 9:37 AM
	NeoGenomics reports revenue rose almost 160 percent in second quarter - Naples Daily News (NASDAQ:NEO) www.naplesnews.com - July 27 at 6:44 PM
	NeoGenomics Reports 159% Revenue Growth to $63.1 Million and Strong Gains in Profitability in the Second Quarter of 2016 (NASDAQ:NEO) www.kswo.com - July 27 at 9:24 AM
	NeoGenomics reports revenue rose almost 160 percent in second quarter (NASDAQ:NEO) www.naplesnews.com - July 27 at 9:24 AM
	Edited Transcript of NEO earnings conference call or presentation 26-Jul-16 3:00pm GMT (NASDAQ:NEO) finance.yahoo.com - July 26 at 7:02 PM
	BRIEF-NeoGenomics Q2 adjusted earnings per share $0.04 (NASDAQ:NEO) www.reuters.com - July 26 at 6:43 PM
	NEOGENOMICS INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) (NASDAQ:NEO) www.4-traders.com - July 26 at 6:43 PM
	NEOGENOMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:NEO) biz.yahoo.com - July 26 at 11:05 AM
	BRIEF-NeoGenomics Q2 adjusted earnings per share $0.04 - Reuters (NASDAQ:NEO) www.reuters.com - July 26 at 9:38 AM
	NeoGenomics Inc.: NeoGenomics Reports 159% Revenue Growth to $63.1 Million and Strong Gains in Profitability in ... - The Wall Street Transcript (NASDAQ:NEO) www.twst.com - July 26 at 9:38 AM
	Margins Are Key For NeoGenomics In Q2 2016 - Seeking Alpha (NASDAQ:NEO) seekingalpha.com - July 26 at 9:38 AM
	NeoGenomics reports 2Q loss (NASDAQ:NEO) sg.finance.yahoo.com - July 26 at 7:27 AM
	Investor Calendar Invites You to the NeoGenomics Second Quarter 2016 Earnings Conference Call and Webcast Live on Tuesday, July 26, 2016 (NASDAQ:NEO) finance.yahoo.com - July 25 at 4:10 PM
	NeoGenomics, Inc. (NASDAQ:NEO): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:NEO) www.engelwooddaily.com - July 22 at 9:21 AM
	Brokers Issue Average Price Target Of 8.50 On NeoGenomics, Inc. (NEO) - Fiscal Standard (NASDAQ:NEO) www.fiscalstandard.com - July 22 at 9:21 AM
	Is Buying All-time Stock Like NeoGenomics, Inc. a Winning Strategy? - Consumer Eagle (NASDAQ:NEO) www.consumereagle.com - July 22 at 9:21 AM
	NeoGenomics, Inc. : half-yearly earnings release (NASDAQ:NEO) www.4-traders.com - July 21 at 6:42 PM
	New Broker Ratings For NeoGenomics, Inc. (NEO) - FTSE News (NASDAQ:NEO) www.ftsenews.co.uk - July 20 at 9:20 AM
	Equity Roundup: Stock Performance Focus on NeoGenomics, Inc. (NASDAQ:NEO) - Press Telegraph (NASDAQ:NEO) presstelegraph.com - July 20 at 9:20 AM
	Share Performance Summary for: Neogenomics Inc. (NASDAQ:NEO) - Press Telegraph (NASDAQ:NEO) presstelegraph.com - July 19 at 9:55 AM
	Neogenomics Inc versus Pacific Biosciences of California Inc Head to Head Compare - CML News (NASDAQ:NEO) news.cmlviz.com - July 19 at 9:55 AM
	NeoGenomics, Inc. – Value Analysis (NASDAQ:NEO) : July 18, 2016 (NASDAQ:NEO) www.capitalcube.com - July 18 at 4:04 PM
	Shares Moving Down on the Week: Neogenomics Inc. (NASDAQ:NEO) - Engelwood Daily (NASDAQ:NEO) www.engelwooddaily.com - July 17 at 5:49 PM
	Neogenomics Incorporated (NASDAQ:NEO) Sellers Increased By 8.74% Their Shorts - Consumer Eagle (NASDAQ:NEO) www.consumereagle.com - July 17 at 10:40 AM
	NeoGenomics, Inc. (NASDAQ:NEO) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:NEO) www.engelwooddaily.com - July 15 at 11:13 AM

Social

NeoGenomics (NASDAQ:NEO) Chart for Sunday, September, 25, 2016